A National Leader in Pediatric Heart Transplantation
NewYork-Presbyterian/Morgan Stanley Children's Hospital has one of the largest pediatric heart transplant programs in the United States and ranks in the nation's top five centers for pediatric heart transplant. Our surgeons typically perform more than 25 transplants for pediatric and adult congenital heart disease each year - more than any other hospital in the country. We have also successfully pioneered transplantations in high-risk patients who are not offered heart transplants elsewhere. When you bring your child to us for a heart transplant, you and your family can benefit from our:
- Exceptional Experience: The world's first successful pediatric heart transplant was performed at Columbia Presbyterian Medical Center in 1984 on a four-year-old boy with complex congenital heart disease. Since then, more than 440 children have received new hearts at NewYork-Presbyterian/Morgan Stanley Children's Hospital. Today, NewYork-Presbyterian is one of the largest and most successful pediatric heart transplant centers in North America and the world - largely due to the dedication and expertise of our heart transplant team, the use of assist devices to treat children with heart failure, and our application of novel immunosuppression approaches.
- A Team of Experts: Our multidisciplinary team approach has set the standard of care for children with end-stage heart failure, achieving 84 percent overall long-term survival after hospital discharge. Pediatric heart transplant surgeons, cardiologists, neurologists, pediatric transplant nurses, psychiatrists, social workers, and physical therapists provide the most comprehensive care possible for children with complex conditions.
- Dedicated Care for Cardiomyopathy: Cardiomyopathy is the leading reason for heart transplantation in children. Roughly one in five infants and children with cardiomyopathy that causes symptoms need a transplant within the first year of diagnosis. We specialize in transplanting children with end-stage congestive heart failure due to cardiomyopathy and children with complex congenital heart disease who are not candidates for palliative or corrective surgery. We also have a dedicated Center for Pediatric Cardiomyopathy, Heart Failure and Transplantation, which provides state-of-the-art care for children with complex congenital heart disease and severe heart disorders.
- Pediatric Cardiac Critical Care: The Pediatric Cardiac Intensive Care Unit (CICU) serves the needs of critically ill infants, children, and adolescents in need of specialized heart care, including those recovering from a heart transplant. This specialized unit is staffed by a highly skilled team of intensivists from multiple subspecialties, including anesthesiology, pediatric cardiology, pediatric heart surgery, neonatology (newborn care), critical care, and pulmonology (lung care).
- Survival Rates Exceeding the National Average: While we treat children with some of the most complex heart problems, our survival rates surpass the national average, with children routinely returning to normal levels of activity after transplant and living into adulthood. Our overall hospital discharge mortality rate was only 2.3 percent (versus the 3.2 percent national benchmark).
- Leadership in Research: NewYork-Presbyterian/Morgan Stanley Children's has a leadership role in the Pediatric Heart Transplant Study Group, which consists of 23 institutions across North America and is responsible for a significant proportion of multi-institutional research related to pediatric heart transplantation today.